|
|
Bardoxolone Improves Kidney Function in CKD Out to 1 Year - Medscape |
Medscape
These results, published online today in the New England Journal of Medicine, mirror those seen at 24 weeks (as reported at the 2010 meeting of the American Society of Nephrology), suggesting that the drug might be useful for the treatment of CKD.
|
|
|
ERA-EDTA Congress 2011: Late Breaking Clinical Trials I - Sacramento Bee |
Sacramento Bee
Other renal function parameters (creatinine and urea) were also better in the Bardoxolone group. Reader comments on Sacbee.com are the opinions of the writer, not The Sacramento Bee. If you see an objectionable comment, click the flag icon below it.
|
|
Bardoxolone Improves eGFR Out to One Year in Advanced CKD - Renal and Urology News |
Renal and Urology News
Improvements in estimated glomerular filtration rate (eGFR) at 52 weeks in the BEAM trial were consistent with six-month data presented last year at the American Society of Nephrology annual meeting. The latest results, published today online by the
|
|
ReportsnReports- Interventional Neurology - Global Pipeline Analysis ... - SBWire (press release) |
SBWire (press release)
ReportsnReports.com adds GlobalData Market Research Reports 'Renal Dialysis Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017' to its store. Dallas, TX -- (SBWIRE) -- 06/24/2011 -- GlobalData's new report,
|
|
Amgen Announces Modifications to U.S. Prescribing Information for Use of ... - PR Newswire (press release) |
PR Newswire (press release)
The modified language, including changes to the Boxed Warning, provides important new information for the treatment of patients with CKD who are on dialysis, as well as those not on dialysis, to inform prescribers and patients of safety risks that have
|
|
|
|
|
<< Start < Prev 831 832 833 834 835 836 837 838 839 840 Next > End >>
|
|
Page 837 of 2630 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
